Homepage > Company > Media > Pharma News > 2019 > Turkey to increase fixed exchange rate for pharma products by 26.4 percent: NTV

Turkey to increase fixed exchange rate for pharma products by 26.4 percent: NTV

ISTANBUL (Reuters) - Turkey increased on Wednesday the fixed exchange rate by 26.4 percent for pharmaceutical products that are imported, Health Minister Fahrettin Koca was reported as saying by broadcaster NTV.

The exchange rate for pharmaceuticals in 2018 was 2.6934 lira to the euro - barely half the current market rate, which caused a scarcity in essential drugs in the past weeks.

FEBRUARY 13, 2019

https://www.reuters.com/

Read also

EC approves AstraZeneca’s Fasenra for EGPA treatment

The European Commission (EC) has approved AstraZeneca‘s Fasenra (benralizumab) as an add-on therapy for adults with relapsing or refractory eosinophilic granulomatosis with polyangii...

Genprex reports positive preclinical gene therapy data

Genprex, Inc., a clinical-stage gene therapy company, announced positive preclinical results for its lead drug candidate, Reqorsa® (quratusugene ozeplasmid) Gene Therapy, at the recent EORTC-...

Astellas withdraws Europe ACP application for AMD treatment

Astellas Pharma has announced the withdrawal of its marketing authorisation application for IZERVAY (avacincaptad pegol, ACP) intravitreal solution to treat geographic atrophy (GA) sec...

New report demands greater understanding of the impact of change on academia

Digital Science, a technology company serving stakeholders across the research ecosystem, is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having ...